Source: Medtech Dive

Recently，Global medical technology giant BD (BD) Announced the launch ofHemoSphere AltaSurgical Monitoring Platform: This system innovatively integrates artificial intelligence algorithms with multimodal physiological monitoring technology to predict the risk of intraoperative blood pressure crises in real time.As BD Medical's last year's42Billion-dollar acquisition of Edwards Life Sciences (Edwards Lifesciences) The first flagship product released after the patient monitoring business,HemoSphere AltaMarks the official entry into the field of surgical monitoring“AIDrive-based Active Intervention”Era.

HemoSphere AltaThe core innovation lies in its original“Cerebral Autoregulation Index (Cerebral Autoregulation Index, CAI）”Monitoring function. The system achieves precise prediction through the following technical pathways:

Multi-parameter Fusion Acquisition:

Non-invasive oxygen sensor: Attached to the patient's forehead, continuously monitoring cerebral tissue oxygen saturation (rSO₂）；

Arterial Catheter Cardiac Output Monitoring: Real-time hemodynamic data obtained through radial or femoral artery catheterization.

AIModel Construction:

The deep learning algorithm equipped in the system can dynamically analyze.CAIValue——This index reflects the brain's ability to maintain stable cerebral blood flow during fluctuations in blood pressure (such as hypotensive hemorrhage). WhenCAIWhen the value exceeds the individualized threshold, the system will trigger a three-level warning mechanism.

Predictive Intervention Support:

Except for real-time displayCAITrends aside, the platform can prepare in advance.8-12Minute Prediction of Sudden Drop in Oxygen Saturation (SpO₂<90%) and Mean Arterial Pressure (MAP）<65mmHgEvent, Accuracy Rate89%。

Traditional monitors can only reflect physiological parameter changes that have already occurred, whileHemoSphere AltaThroughAIModeling Implementation“From Monitoring to Early Warning”A leap forward. For example, in neurosurgical procedures, the system can pre-identify patients with impaired cerebral vascular autoregulation to prevent postoperative cognitive dysfunction caused by blood pressure fluctuations.

For high-intensity work scenarios in the operating room,HemoSphere AltaAchieve multiple breakthroughs at the human-computer interaction level:

Touch-free Control: Supports voice commands (e.g.“Increase Alarm Threshold”`) and gesture recognition (such as hovering to retrieve trend graphs), reducing the frequency of medical staff touching the screen and lowering the risk of infection;`

Dynamic Interface Layout: Automatically adjust display priority based on the surgical phase, such as highlighting blood pressure trends during the anesthesia induction period and enlarging electroencephalogram signals during the neuromonitoring phase;

Sterile Adapter: Compatible with disposable sensor components throughISO 13485Certified, compatible with various operating room sterilization processes.

User Feedback: In the pilot conducted at Mayo Clinic, the number of intraoperative touchscreen operations by anesthesiologists decreased after using the system.72%, the alarm response time is shortened to3.2Seconds (Industry Average)5.8Seconds).

BD Medical willHemoSphere AltaPositioned as“Operating Room Decision Hub”, with a focus on the following areas:

High-risk surgeries for bleeding: such as liver transplantation, spinal correction, the system can monitor in real time the compensatory vasoconstriction caused by blood loss;

Neurosurgical Intensive Care: During Aneurysm Clipping Surgery,CAIGuided Blood Pressure Management Reduces the Incidence of Cerebral Ischemia41%；

Surgery for elderly patients: High-risk populations with comorbid arteriosclerosis,AIPredictive models can optimize vasoactive drug titration strategies.

Competitive Analysis: Compared with General Electric (GE) ofCARESCAPESeries,HemoSphere AltaThe advantage lies in:

Specialized Algorithm: Built-in23Monitoring protocol dedicated to this type of surgery;

Data Integration Capability: Seamless connection with BD MedicalInfusionInfusion Management System, Forming a Closed-Loop Treatment Circuit.

WithHemoSphere AltaThe listing has led to three major paradigm shifts in the field of surgical monitoring:

From Parameter Monitoring to Physiological Reserve Assessment:CAIDynamic indicators such as ... replace traditional static thresholds, more accurately reflecting organ tolerance limits;

From Passive Response to Proactive Intervention:AIPrediction enables healthcare professionals to initiate preventive measures before a physiological crisis occurs;

From Equipment Isolation to System Collaboration: Through OpeningAPIInterface, monitoring data can be transmitted to electronic medical records in real time (EMR) and Operating Room Information Management System (ORIS）。

John·Director of Anesthesiology and Critical Care at Johns Hopkins HospitalSteven FrankThe professor pointed out:“HemoSphere AltaRepresents the Future Direction of Surgical Monitoring——Providing actionable insights within the golden hours, rather than merely recording historical data. This shift is no less valuable for improving surgical safety than the invention of the anesthesia machine.”

BD MedicalHemoSphere AltaThe launch not only marks a generational upgrade in surgical monitoring technology but also heraldsAIReshaping the underlying logic of perioperative management. With the platform's deepening application in fields such as cardiac intervention and organ transplantation, a revolution is underway with“Visualization of Physiological Reserves”A medical revolution at the core has already begun.

(Source of this article's data: BD official press release,FDA 510(k)Certification Documents, John·Johns Hopkins Hospital Clinical Validation Report